Moving beyond chemotherapy? Why some breast cancer clinical trials suggest we may be close

Today’s breast cancer trials aren’t just testing small improvements. Many are exploring entirely new ways to treat cancer, reduce side effects, and personalize care. Understanding what is being studied right now can help you have more informed conversations with your care team and feel more confident about what may be available to you.

Clinical trials are how new treatments become available. Every therapy used in breast cancer today was once studied in a clinical trial. It’s important to understand that trials are not only for patients who have run out of options. Many are designed for people at earlier stages of disease or those starting a new line of therapy. In some cases, they offer access to treatments that may be more effective or better tolerated than current standards, and a trial is the only way to access the innovation.

Evidence-based guidance powered by NCCN Guidelines®

Personalized treatment plans shaped by the latest oncology standards—tailored to your diagnosis.

Get started

View your personalized treatment plan in the Outcomes4Me app

Use your diagnosis to unlock personalized NCCN Guidelines®-aligned recommendations.

Continue in app

Chemotherapy has been a cornerstone of breast cancer treatment for decades and remains an important part of care today. At the same time, clinical trials are actively exploring whether some patients can safely receive less chemotherapy or, in select cases, avoid it altogether. These studies are often focused on specific groups, such as people with triple-negative or BRCA-related breast cancer, and are testing combinations of targeted therapy and immunotherapy. Early results from several trials have shown promising response rates, but these approaches are still being studied and are not yet standard for most patients. 

This doesn’t mean chemotherapy is completely going away, but it does signal a meaningful shift toward more tailored and potentially less toxic treatment approaches. A major area of innovation right now is a class of drugs called antibody-drug conjugates (ADCs), which pair a chemotherapy drug with an antibody that specifically targets cancer cells, allowing treatment to be delivered more precisely while limiting damage to healthy tissue. Clinical trials have shown that ADCs can improve outcomes in metastatic breast cancer, including for patients who have already received multiple prior therapies, and they are quickly becoming an important part of treatment across different subtypes. 

At the same time, research in hormone receptor-positive (HR+) breast cancer, the most common subtype, is advancing with the development of oral selective estrogen receptor degraders (SERDs). These medications are designed to more effectively block estrogen signaling, particularly in cancers that have become resistant to standard hormone therapies, and some may become new standards of care in the coming years for patients whose disease has progressed on earlier endocrine treatment.

Breast cancer research is moving quickly, and clinical trials are at the center of that progress. From chemotherapy-free approaches to more targeted therapies, today’s studies are focused on improving both outcomes and quality of life. Depending on your diagnosis, stage, and prior treatments, there may be trials available that are appropriate for you now or in the future. The challenge is often knowing where to look and how to determine if a trial is a good fit.

If you’re interested in clinical trials, consider asking your care team:

• Are there any clinical trials that match my specific type of breast cancer?
• What are the potential benefits and risks compared to standard treatment?
• Would joining a trial affect my other treatment options later?

These conversations can help you better understand your options and make decisions that align with your goals. Not every trial will be right for every patient, but understanding what is being studied can help you feel more informed and more in control of your care.

If you want help exploring clinical trials that may be relevant to your diagnosis, tools like Outcomes4Me can help you review personalized treatment options and identify opportunities to discuss with your care team.